Exosomes: an innovative therapeutic target for cerebral ischemia-reperfusion injury
Frontiers in Pharmacology · 26.03.2025 · 16
DOI: 10.3389/fphar.2025.1552500 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 26.03.2025. Verfasst von Yuan Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The Second Affiliated Hospital, Kunming Medical University, Kunming, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ischemic stroke is caused by artery stenosis or occlusion, which reduces blood flow and may cause brain damage. Treatment includes restoring blood supply; however, ischemia-reperfusion can still aggravate tissue injury. Reperfusion injury can increase levels of reactive oxygen species, exacerbate mitochondrial dysfunction, create excessive autophagy and ferroptosis, and cause inflammation during microglial infiltration. Cerebral ischemia-reperfusion injury (CIRI) is a key challenge in the treatment of ischemic stroke. Currently, thrombolysis (e.g., rt-PA therapy) and mechanical thrombectomy are the primary treatments, but their application is restricted by narrow therapeutic windows (<4.5 h) and risks of hemorrhagic complications. Exosomes reduce CIRI by regulating oxidative stress, mitochondrial autophagy, inflammatory responses, and glial cell polarization. In addition, their noncellular characteristics provide a safer alternative to stem cell therapy. This article reviews the research progress of exosomes in CIRI in recent years.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, The Second Affiliated Hospital, Kunming Medical University, Kunming, China.
- Department of Anesthesiology, The First Affiliated Hospital, Kunming Medical University, Kunming, China.
Zitieren
APA
Yang, Y., Duan, Y., Yue, J., Yin, Y., Ma, Y., Wan, X., & Shao, J. (2025). Exosomes: an innovative therapeutic target for cerebral ischemia-reperfusion injury. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1552500
Vancouver
Yang Y, Duan Y, Yue J, Yin Y, Ma Y, Wan X, et al. Exosomes: an innovative therapeutic target for cerebral ischemia-reperfusion injury. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1552500
BibTeX
@article{Yang2025,
author = {Yang, Yuan and Duan, Yushan and Yue, Jinxi and Yin, Yue and Ma, Yiming and Wan, Xiaohong and Shao, Jianlin},
title = {Exosomes: an innovative therapeutic target for cerebral ischemia-reperfusion injury},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1552500}
}
EUVIMED